Kindora
FeaturesSocial Impact InvestmentsPricing
AboutLive Demos
Sign InSign Up
    Kindora
    FeaturesSocial Impact InvestmentsPricing
    AboutLive Demos
    Sign InSign Up
    1. Home
    3. Foundations
    5. Genentech Patient Foundation
    Genentech Patient Foundation logo

    Genentech Patient Foundation

    ActiveHuman ServicesFunds Individuals
    South San Francisco, CAWebsite4157661252

    About Genentech Patient Foundation

    The Genentech Patient Foundation directs virtually all of its giving to subsidizing patient access to prescription medicines, operating as a large-scale patient assistance program. Its grants are designed to get specialty and branded drugs into the hands of eligible, often underinsured or uninsured patients, indicating a primary focus on removing financial barriers to treatment. The foundation appears programmatic and operational rather than funding a broad set of external nonprofits or diversified causes.

    Focus Areas

    Patient assistance programs providing free or discounted prescription drugsAccess to specialty medicines for underinsured and uninsured patientsCopay and cost-share support for patients on high-cost therapiesSupport targeted to patients of Biotech/Pharmaceutical products (including oncology and rare disease treatments)

    Who They Fund

    patients requiring prescription medication

    Giving Approach

    Extremely concentrated, programmatic giving: very large, direct grants (or in-kind provision) channeled to eligible patients through the foundation’s patient assistance program; few grants overall and repeat funding to the same programmatic recipient population rather than many distinct nonprofit partners.

    About Genentech Patient Foundation

    Genentech Patient Foundation’s defining activity is direct prescription-drug support at very large scale: its three largest recent grants all went to Eligible Patients (See Schedule #2) in South San Francisco, CA for "Provide Prescription Drugs." That pattern makes the foundation look less like a conventional grantmaker and more like a patient assistance program embedded in a corporate giving structure. The foundation’s giving is concentrated on getting Genentech medicines to people in the United States who lack insurance coverage for those drugs or have financial concerns that meet eligibility criteria. Beyond that core function, the foundation also appears in Genentech’s broader corporate giving channels, including requests for proposals, funding request systems, and support for independent co-pay assistance foundations. The stated focus areas around patient assistance, medication access, and prescription drug support point to a program built around helping patients stay on treatment when cost is a barrier. In the recent grant record, the recipients are not external nonprofits but eligible patients, with distributions tied to prescription access rather than project-based charitable work.

    What Genentech Patient Foundation Funds

    Patient access is the central theme. In 2025, the foundation granted $3,452,010,026 to Eligible Patients (See Schedule #2) in South San Francisco, CA for "Provide Prescription Drugs," continuing a multi-year pattern of direct medicine support. The same model appears in 2024, when it awarded $3,527,679,985 to the same recipient for the same purpose. That direct-service structure aligns with its focus on prescription affordability and medication access for eligible people who lack insurance coverage for Genentech medicine or have financial concerns that meet criteria. The foundation also operates through Genentech’s corporate giving infrastructure. It uses Requests for Proposals, an online Funding Request System, and a channel for support to independent co-pay assistance foundations, which places patient affordability within a wider set of health-equity and access programs.

    How Genentech Patient Foundation Gives

    The recent grant amounts are clustered tightly around a very high per-grant level: p25 is $3,267,473,218, median is $3,354,208,807, and p75 is $3,440,944,396. That narrow spread suggests a standardized, programmatic funding pattern rather than widely varying award sizes. The recipient pattern is also highly repetitive. The top three recent grants all went to Eligible Patients (See Schedule #2) across 2023, 2024, and 2025, which points to recurring support rather than one-off awards. Genentech Patient Foundation is classified as a Regular Funder and funds individuals directly, with patient-assistance payments functioning as its main grantmaking mode.

    Financial Snapshot

    Annual Giving

    $10.2B

    Total Assets

    $424.1M

    Total Revenue

    $3.7B

    Total Expenses

    $3.6B

    Typical Grant Size

    Most grants fall between $3.3B and $3.4B, with a median of $3.4B.

    25th Percentile

    $3.3B

    Median

    $3.4B

    75th Percentile

    $3.4B

    Geographic Reach

    Local1 state funded

    About 100% of grants go to recipients in CA.

    Funding intensity
    Low
    High
    Headquarters

    Deep Analysis

    Unlock Deep Analysis

    Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.

    Get Started Free

    Similar Funders

    See Similar Funders

    Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.

    Get Started Free

    Want a Personalized Pitch for Genentech Patient Foundation?

    Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.

    Get Started FreeView Pricing
    Free plan available
    No contracts
    Cancel anytime
    Free Weekly Newsletter

    The Grant Brief

    Weekly grant intelligence for social impact leaders. Curated opportunities, funding trends, and strategic insights — free.

    Join 500+ social impact leaders. Unsubscribe anytime. Privacy Policy

    Trusted by mission-driven teams at organizations nationwide

    Kindora Logo

    At Kindora, we combine data-driven insights with a human touch to create meaningful, strategic fundraising solutions for mission-driven organizations of all sizes.

    Get The Grant Brief — free weekly grant intelligence

    Quick Links

    • Features
    • Social Impact Investments
    • About Us
    • Mission
    • How It Works
    • Pricing
    • Sales deck
    • Philanthropy Jobs
    • Nonprofit Compensation
    • Live demo (every plan)
    • Individual prospecting demoBeta
    • Blog
    • FAQ
    • Getting Started

    Connect With Us

    LinkedInTwitterFacebook

    © 2026 Kindora. All rights reserved.

    Privacy PolicyTerms of ServiceSystem Status
    EIN: 46-0500266
    3 filings on record
    See If You're a Fit — FreeFree account · instant fit score · similar funders

    Funding Style

    direct servicein-kind support (medication provision)targeted program funding

    Notable grantees: Eligible Patients (Genentech Patient Assistance Program)

    Topics

    prescription drug provisionmedication access programspharmaceutical assistanceprescription affordability

    Where Genentech Patient Foundation Makes Grants

    Giving is locally concentrated and entirely in California in the recent grant record: 100% of grants went to recipients in the HQ state, and the top state by grant count is CA. The named recipient location in the recent grants list is South San Francisco, CA, appearing repeatedly across the largest awards. The recipient-country distribution is exclusively US, with 3 grants and no non-US countries represented.

    Frequently Asked Questions About Genentech Patient Foundation

    What does Genentech Patient Foundation fund most directly?

    It funds direct prescription-drug support for eligible patients. The recent grants list shows repeated awards to Eligible Patients (See Schedule #2) for "Provide Prescription Drugs," and the foundation’s stated focus includes patient assistance, medication access, and prescription drug support.

    Who receives support from the foundation?

    The recipient pattern is centered on eligible patients in the United States who lack insurance coverage for Genentech medicine or have financial concerns that meet eligibility criteria. The recent grants also show direct support flowing to Eligible Patients (See Schedule #2) rather than to a broad mix of external nonprofits.

    How large are the typical grants?

    Typical grant sizes are very large and tightly grouped: p25 is $3,267,473,218, the median is $3,354,208,807, and p75 is $3,440,944,396. The three largest recent grants all fall within that same multi-billion-dollar band.

    How does the foundation accept funding requests?

    Genentech uses a Funding Request System (gFRS) for corporate giving, and some channels accept unsolicited submissions while others do not. The foundation’s listed intake options include the general portal, Requests for Proposals, and Independent Medical Education grants, each tied to specific corporate giving processes.

    Does the foundation focus on one-off grants or recurring support?

    The recent grant record shows recurring support: the same recipient category, Eligible Patients (See Schedule #2), appears in 2023, 2024, and 2025, each time for prescription-drug provision. That pattern indicates an ongoing assistance program rather than isolated awards.

    Latest 990 Filing

    2025

    Source: IRS Form 990-PF, fiscal year 2025.

    Open Grant Opportunities

    Current and upcoming funding from Genentech Patient Foundation that your nonprofit may be able to apply for.

    Open now

    Corporate Giving — Requests for Proposals (RFP)

    Expand access to the scientific and medical workforceAdvance health impact / health equityCommunity-focused health programs+1 more

    Who can apply: Eligibility varies by RFP. General organizational eligibility: IRS-recognized tax-exempt entities (501(c)(3) or 501(c)(6)) or U.S. governmental organizations; ineligible: political/sectarian organizations, individual/group private physician offices, physician-owned entities, small practice charitable foundations, organizations with discriminatory policies. Grant requests should be submitted at least 60 days prior to project start where applicable.

    View & apply
    Open nowRolling / open intake

    Innovation Fund (Genentech Corporate Giving)

    Innovative solutions to disparities in science and medicineProjects expanding access to scientific and medical workforcePrograms advancing health impact and inclusive healthcare

    Who can apply: Not fully specified on site. General corporate giving eligibility (IRS tax-exempt nonprofits, public entities) applies. Innovation Fund appears to be invitation-led with limited rolling submissions.

    Deadline: No public deadline; limited rolling submissions accepted. Many awards are by invitation.

    View & apply

    Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.

    Create a free account

    Deadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.

    Recent Grants

    Most recent grants reported to the IRS.

    RecipientLocationAmountYearPurpose
    Eligible Patients (See Schedule #2)South San Francisco, CA$3,452,010,0262025Provide Prescription Drugs
    Eligible Patients (See Schedule #2)South San Francisco, CA$3,527,679,9852024Provide Prescription Drugs
    Eligible Patients (See Schedule #2)South San Francisco, CA$3,180,737,6292023Provide Prescription Drugs

    Eligible Patients (See Schedule #2)

    $3,452,010,026
    South San Francisco, CA2025

    Provide Prescription Drugs

    Eligible Patients (See Schedule #2)

    $3,527,679,985
    South San Francisco, CA2024

    Provide Prescription Drugs

    Eligible Patients (See Schedule #2)

    $3,180,737,629
    South San Francisco, CA2023

    Provide Prescription Drugs